<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00489723</url>
  </required_header>
  <id_info>
    <org_study_id>0056-07-EMC</org_study_id>
    <nct_id>NCT00489723</nct_id>
  </id_info>
  <brief_title>Is There is a Role of Prophylactic Therapy With Tamsulosin Before Extracorporeal Shock Wave Lithotripsy to Avoid Development of Steinstrasse ?</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>HaEmek Medical Center, Israel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>HaEmek Medical Center, Israel</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if there is a role of prophylactic therapy with
      tamsulosin prior extracorporeal shock wave lithotripsy to avoid development of steinstrasse.
      150 persons that will go to Extracorporeal shock wave lithotripsy will randomize to 2 groups.

      Group 1 -of 75 persons will recieve tamsulosin 0.4 mg x 1/d 2 days before the lithotripsy .

      Group 2 - of 75 persons will not recieve tamsulosin. 48 hour after the ESWL all 2 group will
      take abdominal radiograph to evaluate the presence of steinstrasse.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2007</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Screening</primary_purpose>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Longitudinal, Prospective</time_perspective>
  </study_design_info>
  <condition>Kidney Stones</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tamsulosin 0.4mg</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  size of stone 1-2 cm

        Exclusion Criteria:

          -  ureteral stricture Presence of internal stent prior use of alfa bloker prior ESWL
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>doron perez</last_name>
    <role>Principal Investigator</role>
    <affiliation>Urology department: Haemek Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>DORON PEREZ, M.D.</last_name>
    <phone>+972-4-6495115</phone>
    <email>perez_do@clalit.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Haemek medical center</name>
      <address>
        <city>Afula</city>
        <zip>18100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>DORON PEREZ, M.D.</last_name>
      <phone>+972-4-6495115</phone>
      <email>perez_do@clalit.org.il</email>
    </contact>
    <investigator>
      <last_name>doron perez, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>June 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 19, 2007</study_first_submitted>
  <study_first_submitted_qc>June 20, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 21, 2007</study_first_posted>
  <last_update_submitted>June 20, 2007</last_update_submitted>
  <last_update_submitted_qc>June 20, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 21, 2007</last_update_posted>
  <keyword>size of stone 1-2 cm</keyword>
  <keyword>Pt. with no use of alfa bloker prior ESWL</keyword>
  <keyword>Pt. without internal stent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tamsulosin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

